文献速递妇科肿瘤

盲态独立中心审查(BICR)对无进展生存期的夸大

Exaggeration of PFS by blinded, independent, central review (BICR).
PubMed 文献 · Ann Oncol · 2019-01-01

该研究通过模拟研究评估盲态独立中心审查(BICR)与研究者评估的无进展生存期(PFS)差异的方法学原因,并在三项BRCA突变卵巢癌试验中验证。结果显示BICR的Kaplan-Meier曲线常被夸大,当BICR与局部PFS相关性较强(≥0.4)且PFS较长时偏倚最大,但风险比(HR)受偏倚影响较小。作者认为BICR中位PFS可能介于观察到的局部与BICR中位数之间,报告时应同时呈现两者。

要点

  • BICR的PFS Kaplan-Meier曲线常被夸大,中位数及其差值可被高估。
  • BICR与局部PFS相关性≥0.4且PFS较长时,KM曲线偏倚最大。
  • 风险比(HR)对上述偏倚的敏感性远低于中位PFS。

核心结论

  • 总体而言,当局部与BICR中位数存在差异时,真实的BICR KM曲线很可能被夸大,其真实中位数可能位于观察到的局部与BICR中位数之间。
  • 只要进行了BICR,数据呈现应始终同时包括BICR和局部结果。
  • 需要进一步研究以找到估计BICR生存曲线的改进方法。

研究设计与样本

  • 模拟研究,并在三项BRCA突变卵巢癌试验的案例研究中验证。
  • 模拟设定:真实BICR中位PFS为19个月,患者每12周评估一次。

主要发现

  • 当BICR与局部PFS相关性为0.4或更高时,估计的KM曲线出现实质性偏倚。
  • 案例研究中,试验组BICR中位PFS比局部中位PFS大6至11个月。
  • BICR的KM曲线常被夸大,中位数及其差值可被高估;风险比(HR)受偏倚影响小得多。

关键数值与推荐

  • 模拟中真实BICR中位PFS为19个月、每12周评估时,BICR与局部PFS相关性≥0.4即出现实质性偏倚。
  • 案例研究试验组中,BICR中位PFS较局部中位PFS大6至11个月。

临床怎么用

  • 原文结论认为,当局部与BICR中位数存在差异时,真实BICR中位数可能位于两者之间。
  • 原文建议进行BICR时,数据呈现应同时包括BICR和局部结果。

局限性

  • 原文结论指出需要进一步研究以找到估计BICR生存曲线的改进方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent published studies have shown meaningful discrepancies between local investigator and blinded, independent, central review (BICR) assessed median progression-free survival (PFS). When the local review but not BICR shows progression, generally, no further assessments are carried out and patients are censored in the BICR analysis, leading to violation of the statistical assumptions of independence between censoring and outcome used in survival analysis methods. METHODS: We carried out a simulation study to assess methodological reasons behind these discrepancies and corroborated our findings in a case study of three BRCA-mutated ovarian cancer trials. We briefly outline possible methodological solutions that may lead to improved estimation of the BICR medians. RESULTS: The Kaplan-Meier (KM) curve for the BICR PFS can often be exaggerated. The degree of bias is largest when there is reasonably strong correlation between BICR and local PFS, especially when PFS is long compared with assessment frequency. This can result in an exaggeration of the medians and their difference; however, the hazard ratio (HR) is much less susceptible to bias. Our simulation shows that when the true BICR median PFS was 19 months, and patients assessed every 12 weeks, the estimated KM curves were materially biased whenever the correlation between BICR and local PFS was 0.4 or greater. This was corroborated by case studies where, in the active arm, the BICR median PFS was between 6 and 11 months greater than the local median PFS. Further research is required to find improved methods for estimating BICR survival curves. CONCLUSIONS: In general, when there is a difference between local and BICR medians, the true BICR KM curve is likely to be exaggerated and its true median will probably lie somewhere between the observed local and BICR medians. Presentation of data should always include both BICR and local results whenever a BICR is carried out.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Stone A, Gebski V, Davidson R, et al. Exaggeration of PFS by blinded, independent, central review (BICR). Ann Oncol. 2019. PMID: 30475951. doi:10.1093/annonc/mdy514

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。